Last Updated: 02/12/2024

Center for Vaccine Innovation and Access (CVIA) – Wave 3

Objectives

To transform the business and operating model for PATH’s vaccine development efforts in order to speed the efficient and effective progression of a vaccine pipeline with industry-standard quality.

Principal Institution

PATH, United States

Principal Investigators / Focal Persons

Jessica Milman

Date

Jun 2022 — May 2026

Total Project Funding

$160.5M

Funding Details
Project Site

United States

SHARE
SHARE